97 related articles for article (PubMed ID: 7008173)
1. [Methodical standardization for the clinical use of the LAI test].
Jandová A; Heyberger K
Sb Lek; 1980; 82(11-12):382-4. PubMed ID: 7008173
[No Abstract] [Full Text] [Related]
2. [Some methodical aspects of the leukocyte adherence inhibition test (LAI)].
Teuber S; Storch H
Z Med Lab Diagn; 1986; 27(3):169-73. PubMed ID: 3524045
[No Abstract] [Full Text] [Related]
3. [Leukocyte adherence inhibition test (LAI)].
Matsumoto Y
Rinsho Byori; 1981 Apr; (Suppl 45):250-64. PubMed ID: 7026839
[No Abstract] [Full Text] [Related]
4. [Leukocyte adherence inhibition test (LAI): instrumentation, procedure and possibilities for use].
Lehmitz R; Grap H; Schulze H; Ziegler K
Z Med Lab Diagn; 1982 Jan; 23(1):49-54. PubMed ID: 7046275
[No Abstract] [Full Text] [Related]
5. The significance of vaginal hormonal cytology and the leukocyte adherence inhibition test for the detection of malignancy.
Kobilková J; Jandová A; Motlík K; Coupek J; Heyberger K
Acta Cytol; 1983; 27(4):417-20. PubMed ID: 6349199
[TBL] [Abstract][Full Text] [Related]
6. [Leukocyte adherence inhibition (LAI) test in patients with chronic liver diseases].
Matsumoto Y; Ishihara J; Yamamoto M
Rinsho Byori; 1985 Apr; 33(4):421-5. PubMed ID: 3900488
[No Abstract] [Full Text] [Related]
7. [Possible use of the LAI test in clinical oncology].
Procházka J; Hasek M; Deyl Z; Sobĕslavský C; Sochorová L
Cas Lek Cesk; 1983 Dec; 122(49):1526-30. PubMed ID: 6360376
[No Abstract] [Full Text] [Related]
8. [Test-tube LAI test in the diagnosis of malignant melanoma].
Hasek M; Holán V; Duchková H; Kubíková M; Sibl O; Kousalová M
Cesk Dermatol; 1982 Jun; 57(3):161-3. PubMed ID: 6749310
[No Abstract] [Full Text] [Related]
9. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer.
De Carli HO; Restbergs V
Rev Esp Oncol; 1983; 30(1):25-39. PubMed ID: 6387830
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study about the use of LAI test and MI test in immunodiagnostics of gynecological tumours (author's transl)].
Jandová A; Svec M; Heyberger K; Laurová L; Novotná J; Roubal J; Trnka V; Vancurik J
Cesk Gynekol; 1979 Feb; 44(1):44-50. PubMed ID: 371825
[No Abstract] [Full Text] [Related]
11. [Tumor immunity and the LAI test].
Hasek M
Cesk Dermatol; 1980 Aug; 55(4):263-5. PubMed ID: 6996845
[No Abstract] [Full Text] [Related]
12. [LAI test in pregnant women (author's transl)].
Knobloch V; Jouja V; Svobodová M
Cesk Gynekol; 1980 Feb; 45(1):10-2. PubMed ID: 6991128
[No Abstract] [Full Text] [Related]
13. [Predictive value of immunological studies in patients with maxillofacial malignancies. 1. Leukocyte adherence inhibition tests (LAI)].
Teuber S; Storch H; Gitt HA
Stomatol DDR; 1984 May; 34(5):266-72. PubMed ID: 6382696
[No Abstract] [Full Text] [Related]
14. [Determination of cell-mediated immuno-reactivity in mycoses using the LAI test].
Skierlo P; Kaben U; Westphal HJ
Mykosen; 1983 Aug; 26(8):393-9. PubMed ID: 6353223
[No Abstract] [Full Text] [Related]
15. The use of the tube leucocyte adherence inhibition (LAI) assay for immunogenetic studies in rats.
Holán V; Hasek M
Folia Biol (Praha); 1978; 24(6):410-1. PubMed ID: 365617
[No Abstract] [Full Text] [Related]
16. Application of tube LAI assay in larynx cancer patients.
Hasek M; Holán V; Síbl O; Kousalová M
Neoplasma; 1981; 28(6):685-8. PubMed ID: 7040994
[TBL] [Abstract][Full Text] [Related]
17. [Modification of leucocyte adherence inhibition (LAI) assay with 51Cr-labelled leucocytes (author's transl)].
Varga A; Stosiek P; Kasper M
Allerg Immunol (Leipz); 1980; 26(2):171-8. PubMed ID: 6449844
[TBL] [Abstract][Full Text] [Related]
18. [Possibility to use the LAI test (leucocyte adherence inhibition) for immunological examination of pregnant women with EPH gestosis (author's transl)].
Soukup K; Jandová A; Kobilková J; Trnka V; Vinsová N; Mejsnarová B; Samitrák J; Coupek J; Heyberger K
Cesk Gynekol; 1981 Aug; 46(7):524-6. PubMed ID: 7026060
[No Abstract] [Full Text] [Related]
19. [Hyperestrinism--a risk factor of malignancy and the LAI test (author's transl)].
Kobilková J; Jandová A; Motlík K; Coupek J; Heyberger K
Sb Lek; 1981; 83(11-12):321-5. PubMed ID: 7034143
[No Abstract] [Full Text] [Related]
20. Tube LAI assay in diagnosis and monitoring of a cancer disease.
Hasek M; Holán V; Kousalová M
Biomedicine; 1981 Dec; 35(7-8):207-8. PubMed ID: 7049257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
